A kind of polypeptide compound for treating polycystic ovary syndrome and its application
A technology for polycystic ovary syndrome, which is applied in the field of polypeptide compounds for the treatment of polycystic ovary syndrome and drugs for the treatment of polycystic ovary syndrome, can solve the problems of poor curative effect, reverse insulin resistance, and improve polycystic ovary syndrome Sign effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Three-week-old SD rats were selected to prepare polycystic ovary syndrome insulin resistance animal models, and drug intervention was performed on the successful model mice.
[0020] ELISA and other methods were used for detection, and statistical software SPSS19.0 was used for analysis to clarify the therapeutic effect and possible mechanism of the polypeptide Met-Trp-Trp-His-His-Met on polycystic ovary syndrome insulin resistance animal models.
[0021] 1. Materials
[0022] 1.1 Experimental animals
[0023] 120 3-week-old SPF female SD rats were raised in the Animal Center of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine. 25°C constant temperature (50% humidity) clean-grade breeding, without feeding vitamin products, 12h light and 12h dark cycle alternately.
[0024] 1.2 Main reagents
[0025] DHEA (Sigma Company), peptide Met-Trp-Trp-His-His-Met (Shanghai Sangong Synthetic), metformin (Shanghai Ziyi Co., Ltd.), blood glu...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
